Table 4.
Patient | AI | Reduction (%) | |
---|---|---|---|
Baseline | After use | ||
1 | 6.4 | 0.3 | 95.2 |
2 | 2.3 | 0.9 | 60.9 |
3 | 2.1 | 8.9 | −322.4 |
4 | 4.9 | 0.8 | 84.7 |
5 | 1.6 | 10.4 | −560.5 |
6 | 16.3 | 8.6 | 47.5 |
7 | 6.3 | 0.5 | 92.0 |
8 | 2.1 | 1.1 | 50.5 |
9 | 9.3 | 0.3 | 96.8 |
10 | 1.2 | 1.3 | −11.8 |
11 | 3.1 | 2.7 | 12.3 |
12 | 4.1 | 12.1 | −195.9 |
13 | 13.9 | 0.6 | 95.8 |
14 | 8.1 | 8.7 | −6.8 |
15 | 2.0 | 11.3 | −454.7 |
16 | 1.9 | 2.9 | −53.9 |
17 | 3.7 | 0.1 | 96.5 |
18 | 15.2 | 0.7 | 95.6 |
19 | 3.3 | 0.6 | 82.3 |
Mean | 5.7 | 3.8 | −36.6 |
SD | 4.8 | 4.4 | 199.7 |